Comparing safety information of biosimilars with their originators: a cross‐sectional analysis of European risk management plans

BACKGROUND AND AIMS: Biosimilars have been available in the European Union (EU) since 2006. However, their uptake in routine care is heterogeneous across countries. The aim of the present study was to compare the safety information of biosimilars and their originators based on the information in the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Clin Pharmacol
Autori principali: Lepelaars, Leroy R. A., Renda, Francesca, Pani, Luca, Pimpinella, Giuseppe, Leufkens, Hubert G. M., Trifirò, Gianluca, Tafuri, Giovanni, Mantel‐Teeuwisse, Aukje K., Trotta, Francesco
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Drug Safety
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5867080/
https://ncbi.nlm.nih.gov/pubmed/29164665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13454
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi